Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosisQUAN LIU; BIAO HE; HUANG, Si-Yang et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 8, pp 763-772, issn 1473-3099, 10 p.Article

The pharmacology and clinical application of thrombopoietin receptor agonistsCAIZHENG LI; LI ZHENG.International journal of hematology. 2014, Vol 100, Num 6, pp 529-539, issn 0925-5710, 11 p.Article

How to use... lupus anticoagulantsSEN, Ethan S; BERESFORD, Michael W; AVCIN, Tadej et al.Archives of disease in childhood. Education and practice edition. 2013, Vol 98, Num 2, pp 52-57, issn 1743-0585, 6 p.Article

Development and implementation of a nurse-driven, sliding-scale nomogram for bivalirudin in the management of heparin-induced thrombocytopeniaBURCHAM, Pamela K; ABEL, Erik E; GERLACH, Anthony T et al.American journal of health-system pharmacy. 2013, Vol 70, Num 11, pp 980-986, issn 1079-2082, 7 p.Article

Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatmentCANTONI, Nathan; HEIZMANN, Marc; BARGETZI, Mario et al.British journal of haematology. 2012, Vol 157, Num 5, pp 639-641, issn 0007-1048, 3 p.Article

Romiplostim for the early management of severe immune thrombocytopenia unresponsive to conventional treatmentTAGARIELLO, Giuseppe; SARTORI, Roberto; RADOSSI, Paolo et al.British journal of haematology. 2012, Vol 157, Num 2, pp 256-258, issn 0007-1048, 3 p.Article

A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopeniaSHUJIE WANG; RENCHI YANG; HUI SUN et al.International journal of hematology. 2012, Vol 96, Num 2, pp 222-228, issn 0925-5710, 7 p.Article

Coagulopathy as a Therapeutic Target for TRALI: Rationale and Possible Sites of Action : Preventive and Therapeutic Strategies for Transfusion-Related Acute Lung InjuryTUINMAN, Pieter R; SCHULTZ, Marcus J; JUFFERMANS, Nicole P et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 22, pp 3267-3272, issn 1381-6128, 6 p.Article

Determining a definite diagnosis of primary immune thrombocytopenia by medical record reviewTERRELL, Deirdra R; BEEBE, Laura A; VESELY, Sara K et al.American journal of hematology. 2012, Vol 87, Num 9, pp 843-847, issn 0361-8609, 5 p.Article

Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in miceMILANOV, Peter; IVANCIU, Lacramioara; ABRISS, Daniela et al.Blood. 2012, Vol 119, Num 2, pp 602-611, issn 0006-4971, 10 p.Article

Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formationSCOTT, David W; LOZIER, Jay N.British journal of haematology. 2012, Vol 156, Num 3, pp 295-302, issn 0007-1048, 8 p.Article

Heterogeneous lengths of copy number mutations in human coagulopathy revealed by genome-wide high-density SNP arrayKIM, Hee-Jin; KIM, Duk-Kyung; KIM, Sun-Hee et al.Haematologica (Roma). 2012, Vol 97, Num 2, pp 304-309, issn 0390-6078, 6 p.Article

How I manage neonatal thrombocytopeniaCHAKRAVORTY, Subarna; ROBERTS, Irene.British journal of haematology. 2012, Vol 156, Num 2, pp 155-162, issn 0007-1048, 8 p.Article

How to manage invasive procedures in children with haemophiliaLJUNG, Rolf C. R; KNOBE, Karin.British journal of haematology. 2012, Vol 157, Num 5, pp 519-528, issn 0007-1048, 10 p.Article

Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsisTUCKER, Erik I; VERBOUT, Norah G; LEUNG, Philberta Y et al.Blood. 2012, Vol 119, Num 20, pp 4762-4768, issn 0006-4971, 7 p.Article

Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITPLEONTYEV, Danila; KATSMAN, Yulia; BRANCH, Donald R et al.Blood. 2012, Vol 119, Num 22, pp 5261-5264, issn 0006-4971, 4 p.Article

Polymorphisms of protein tyrosine phosphatase CD 148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopeniaROLLIN, Jérôme; POUPLARD, Claire; GRATACAP, Marie-Pierre et al.Blood. 2012, Vol 120, Num 6, pp 1307-1316, issn 0006-4971, 10 p.Article

Prolonged remission from eltrombopag in chronic refractory idiopathic thrombocytopenic purpuraNORONHA, V; PHILIP, S. D; JOSHI, A et al.International journal of hematology. 2012, Vol 96, Num 3, pp 380-382, issn 0925-5710, 3 p.Article

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patientsSHAPIRO, Amy D; RAGNI, Margaret V; PETERS, Robert T et al.Blood. 2012, Vol 119, Num 3, pp 666-672, issn 0006-4971, 7 p.Article

Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodiesQINGSHU ZENG; LINGYAN ZHU; MINGLI WANG et al.American journal of hematology. 2012, Vol 87, Num 2, pp 206-208, issn 0361-8609, 3 p.Article

Role of bone marrow transplantation for correcting hemophilia A in miceFOLLENZI, Antonia; RAUT, Sanj; MERLIN, Simone et al.Blood. 2012, Vol 119, Num 23, pp 5532-5542, issn 0006-4971, 11 p.Article

Unintended benefit of anabolic steroid use in hemophilia B LeidenRIMMER, Emily K; SEFTEL, Matthew D; ISRAELS, Sara J et al.American journal of hematology. 2012, Vol 87, Num 1, pp 122-123, issn 0361-8609, 2 p.Article

The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapyFINN, Jonathan D; NICHOLS, Timothy C; SVORONOS, Nikolaos et al.Blood. 2012, Vol 120, Num 23, pp 4521-4523, issn 0006-4971, 3 p.Article

Does My Patient Have a Life- or Limb-Threatening Thrombocytopenia?CONNELL, Nathan T; SWEENEY, Joseph D.Hematology/oncology clinics of North America. 2012, Vol 26, Num 2, issn 0889-8588, ix, 369-382 [15 p.]Article

Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpuraTINGTING WANG; ZHAO WANG; RENCHI YANG et al.Critical reviews in oncology/hematology. 2011, Vol 77, Num 3, pp 172-183, issn 1040-8428, 12 p.Article